Enhancing Histopathology with AI – Will This Be A Reality Soon?
- Qritive
- Mar 7, 2023
- 1 min read
Updated: 3 days ago
We have a panel of 3 eminent speakers who will discuss Artificial intelligence and its application in the Histopathology lab. Each of our speakers has experience in histopathology and also with the use of AI tools.
About our speakers:
Dr. RAVI GAUR
Founder & Director DRG Path Labs (Unipath DRG Specialty Laboratory -LLP ),
Delhi-Chairman Medical Advisory Board,
Unipath Specialty Laboratory Ltd, Ahmedabad-Chairman CII healthcare & Wellness Delhi Chapter.
Dr. K.V.SANTOSH
Senior Consultant Pathologist, RV Metropolis, Bengaluru.
Ex Prof. of Pathology
Special interest in AI Pathology, GI Pathology and Dermatopathology
Dr. ANKUR KUMAR
Attending Consultant Pathologist, Rajiv Gandhi cancer Institute & Research Centre, New Delhi.
Special interest in Oncopathology and Digital Pathology
About Qritive
Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.
By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.
Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.
Get in Touch
Want to learn more about our solutions or explore potential collaborations?
Visit www.qritive.com or contact us at info@qritive.com